GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $200,000 | – | 2,520 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
Grace Capital | 98,939 | $13,970,000 | 5.34% |
GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |